-
Mashup Score: 0Cutaneous T-Cell Lymphoma - 7 month(s) ago
Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Guidance from the FDA has provided a clear pathway and requested no additional efficacy or safety trials for the resubmission of the biologics license application for denileukin diftitox in cutaneous T-cell lymphoma.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #FDA has provided additional guidance for the planned resubmission of the BLA for denileukin diftitox for the treatment of patients with relapsed or refractory #CTCL after at least 1 prior systemic therapy. #lymsm https://t.co/JcCcKD43m5
-
-
Mashup Score: 0Cutaneous T-Cell Lymphoma - 8 month(s) ago
Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our learning page on Cutaneous T-Cell Lymphoma #CTCL @skinlymphoma #checkrare #rarediseases #cutaneouslymphoma https://t.co/yBk2J3suJQ
-
-
Mashup Score: 0Exciting research in CTCL: genomics, the tumor microenvironment and the potential role of MRD - 8 month(s) ago
Pierluigi Porcu, MD, Jefferson Health, Sidney Kimmel Cancer Center, Philadelphia, PA, discusses ongoing research in the field of cutaneous T-cell lymphoma (CTCL). Dr Porcu highlights several interesting areas being explored, including genomic research using single-cell analysis, the tumor microenvironment, and studies exploring the potential role of MRD as a strategy to redefine disease stage. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. Pierluigi Porcu talked to @VJHemOnc at @icmlconf about the latest in cutaneous T-cell lymphoma #CTCL, including genomics, the tumor microenvironment, and the potential role of MRD as a strategy to redefine disease stage #ICML2023 https://t.co/FWJxH5DIpp
-
-
Mashup Score: 8Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series - 8 month(s) ago
In advanced stages, Cutaneous T-cell lymphomas (CTCL) can metastasize to extracutaneous regions. CTCL with metastasis exhibits unique clinicopathologi…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Happy to present our work on metastatic #CTCL that I started as a fellow. Kudos to the team for taking it to the finish line! #Hemepath #Dermpath #CutaneousLymphoma Full text at https://t.co/SrtrBaHKW5 https://t.co/2ASIfqygVW
-
-
Mashup Score: 3
Key Points. 1- CTCL cells arise from heavily mutated hematopoietic stem cells after thymic egression.2- Differentiated CTCL cells undergo clonal enrichment whic
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#Hematology #Sézary syndrome originates from heavily mutated hematopoietic progenitors | @BloodAdvances | American Society of Hematology @ASH_hematology #ctcl #lymsm https://t.co/VKzLDc5sKj
-
-
Mashup Score: 1Cutaneous T-Cell Lymphoma - 9 month(s) ago
Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our learning page on Cutaneous T-Cell Lymphoma #CTCL @skinlymphoma #checkrare #rarediseases #cutaneouslymphoma https://t.co/yBk2J3suJQ
-
-
Mashup Score: 0DMF Demonstrates Efficacy in R/R CTCL | ASH Clinical News | American Society of Hematology - 9 month(s) ago
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. Dimethyl fumarate (DMF) was effective in the treatment of relapsed and refractory (R/R) cutaneous T-cell lymphoma (CTCL), according to finding s from a multicenter phase II study published in Blood. “DMF is a promising new therapeutic approach, especially for combination therapy, as no cumulative toxicities are expected,” said author Jan Nicolay, MD, MSc, of University Medical Center Mannheim in Germany. Mycosis fungoides (MF)
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Based on results from a recent multicenter phase II study, #DimethylFumarate was effective in the treatment of relapsed and refractory cutaneous #Tcell #lymphoma #CTCL, with 17% of study participants experiencing severe adverse events https://t.co/mM4WCx2n37
-
-
Mashup Score: 0CTCL: Challenges of Treating People of Color - 9 month(s) ago
Luis Malpica Castillo, MD, The University of Texas MD Anderson Cancer Center, discusses cutaneous T-cell lymphoma (CTCL) and the challenges of treating people of color.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Luis Malpica Castillo, MD, discusses cutaneous T-cell lymphoma #CTCL and the challenges of treating people of color #checkrare #rarediseases @skinlymphoma https://t.co/C1UJc5lj4L
-
-
Mashup Score: 0Cutaneous T-Cell Lymphoma - 10 month(s) ago
Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our learning page on Cutaneous T-Cell Lymphoma #CTCL @skinlymphoma #checkrare #rarediseases #cutaneouslymphoma https://t.co/yBk2J3suJQ
-
Check out our learning page on Cutaneous T-Cell Lymphoma #CTCL @skinlymphoma #checkrare #rarediseases #cutaneouslymphoma https://t.co/yBk2J3t2zo